ZINNAT

País: Indonésia

Língua: indonésio

Origem: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Ingredientes ativos:

CEFUROXIME AXETIL

Disponível em:

GLAXO WELLCOME INDONESIA - Indonesia

DCI (Denominação Comum Internacional):

CEFUROXIME AXETIL

Dosagem:

300.72 MG

Forma farmacêutica:

TABLET SALUT SELAPUT

Unidades em pacote:

DUS, 1 BLISTER @ 10 TABLET SALUT SELAPUT

Fabricado por:

GLAXO OPERATIONS UK LTD TRADING AS GLAXO WELLCOME OPERATIONS - United Kingdom

Data de autorização:

2022-03-22

Características técnicas

ERS_leaZINtab_GDS25-IPI05posologi_circ3_05Feb20
Page 1 of 6
ZINNAT
Cefuroxime axetil
QUALITATIVE AND QUANTITATIVE COMPOSITION
_ZINNAT_ tablets containing either 250 mg or 500 mg of cefuroxime (as
cefuroxime axetil).
PHARMACEUTICAL FORM
Film coated tablet.
CLINICAL PARTICULARS
INDICATIONS
_ZINNAT_ is indicated for the treatment of infections caused by
susceptible bacteria. _ _
Indications include:
–
upper respiratory tract infections for example, ear, nose and throat
infections, such as otitis media,
sinusitis, tonsillitis and pharyngitis.
–
lower respiratory tract infections for example, pneumonia, acute
bronchitis, and acute exacerbations
of chronic bronchitis.
–
genito-urinary tract infections for example, pyelonephritis, cystitis
and urethritis.
–
skin and soft tissue infections for example, furunculosis, pyoderma
and impetigo.
–
gonorrhoea, acute uncomplicated gonococcal urethritis, and cervicitis.
–
treatment of early Lyme disease and subsequent prevention of late Lyme
disease in adults and
children over 12 years old.
Cefuroxime is also available as the sodium salt (cefuroxime sodium)
for parenteral administration. This
permits the use of sequential therapy with the same antibiotic, when a
change from parenteral to oral
therapy is clinically indicated.
Where appropriate _ZINNAT_ is effective when used following initial
parenteral cefuroxime sodium in the
treatment of pneumonia and acute exacerbations of chronic bronchitis.
DOSAGE AND ADMINISTRATION
The usual course of therapy is seven days (range 5 to 10 days).
_ZINNAT_ should be taken after food for optimum absorption.
•
ADULTS
Most infections
250 mg twice daily
Urinary tract infections
250 mg twice daily
Mild to moderate lower respiratory tract infections e.g. bronchitis
250 mg twice daily
More severe lower respiratory tract infections, or if pneumonia is
suspected
500 mg twice daily
Pyelonephritis
250 mg twice daily
Uncomplicated gonorrhoea
single dose of 1 g
Lyme disease in adults and children over the age of 12 years
500 mg twice daily for